Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Neil Niren

Dermatology Pittsburgh, PA Medical Doctor

NPI 1508838061 CMS profile 295475

9102 Babcock Blvd, Ste 206, Pittsburgh, PA 15237

Open in the dashboard

General payments

$573,891

685 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Neil Niren of Pittsburgh, PA is reported in the CMS Open Payments database as having received $573,891 across 685 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $71 2
2024 General $122 2
2023 General $53,562 40
2022 General $142,779 139
2021 General $62,911 75
2020 General $82,339 136
2019 General $232,108 291

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Neil Niren
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Neil Niren were reported at $71. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Neil Niren Dermatology median Middle half National median
2019 $232,108 $454 $129–$1,240 $163
2020 $82,339 $235 $81–$756 $114
2021 $62,911 $377 $108–$1,108 $132
2022 $142,779 $514 $143–$1,391 $149
2023 $53,562 $607 $159–$1,674 $160
2024 $122 $751 $204–$1,903 $164
2025 $71 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Scientific Affairs, LLC $361,202 281 payments
  2. Novartis Pharmaceuticals Corporation $86,277 90 payments
  3. Janssen Biotech, Inc. $54,134 69 payments
  4. Celgene Corporation $30,116 34 payments
  5. Amgen Inc. $29,618 32 payments
  6. Almirall LLC $6,066 6 payments
  7. Sun Pharmaceutical Industries Inc. $1,677 8 payments
  8. Galderma Laboratories, L.P. $1,281 6 payments
  9. VYNE Pharmaceuticals Inc. $1,006 21 payments
  10. Journey Medical Corporation $761 34 payments
  11. Other $1,753 104 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $428,383 138 payments
  2. Travel and Lodging $111,291 150 payments
  3. Consulting Fee $17,735 7 payments
  4. Food and Beverage $13,988 385 payments
  5. Honoraria $2,400 2 payments
  6. Education $94 3 payments
Products named General payments · program years 2019–2025
  1. TREMFYA $415,357 350 payments
  2. COSENTYX Dermatology $68,714 74 payments
  3. Otezla Dermatology $30,035 28 payments
  4. Otezla Inflammation $20,644 26 payments
  5. COSENTYX Immunology $17,489 15 payments
  6. Otezla Inflammation $8,973 6 payments
  7. Klisyri $2,500 2 payments
  8. ILUMYA $1,677 8 payments
  9. AKLIEF $1,273 5 payments
  10. AMZEEQ $981 17 payments
  11. Other $4,387 207 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

685 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record